Ribocure Pharmaceuticals

Ribocure Pharmaceuticals is a newly established biotechnology company headquartered in Sweden, dedicated to advancing the field of cutting-edge RNA therapies. Our mission is to build a world-leading company in RNA research and development, ultimately bringing positive impacts to patients worldwide. Ribocure primarily focuses on addressing significant unmet medical needs in rare diseases within the cardiovascular, renal, and oncology fields. The company is committed to discovering and developing breakthrough drug assets using advanced oligonucleotide technology.